Cited 0 time in
Pan-Asian consortium for treatment and research in ALS (PACTALS) guidelines for management of amyotrophic lateral sclerosis
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Vucic, Steve | - |
| dc.contributor.author | Shahrizaila, Nortina | - |
| dc.contributor.author | Kano, Osamu | - |
| dc.contributor.author | Menon, Parvathi | - |
| dc.contributor.author | Agustini, Sheila | - |
| dc.contributor.author | Kulkantrakorn, Kongkiat | - |
| dc.contributor.author | Atchayaram, Nalini | - |
| dc.contributor.author | Lee, Yi-Chung | - |
| dc.contributor.author | Prado Jr, Mario B. | - |
| dc.contributor.author | Ng, Kay W. P. | - |
| dc.contributor.author | Chai, Josiah | - |
| dc.contributor.author | Son, Bugyeong | - |
| dc.contributor.author | Talman, Paul | - |
| dc.contributor.author | Nghia, Hoang Tien Trong | - |
| dc.contributor.author | Tuan, Le Tu Quoc | - |
| dc.contributor.author | Shibuya, Kazumoto | - |
| dc.contributor.author | Izumi, Yuishin | - |
| dc.contributor.author | Atsuta, Naoki | - |
| dc.contributor.author | Henderson, Robert D. | - |
| dc.contributor.author | Cui, Liying | - |
| dc.contributor.author | Liu, Mingsheng | - |
| dc.contributor.author | Ohnmar, Ohnmar | - |
| dc.contributor.author | Rabani, Remli | - |
| dc.contributor.author | Hong, Yoon-Ho | - |
| dc.contributor.author | Sung, Jung-Joon | - |
| dc.contributor.author | Fan, Dongsheng | - |
| dc.contributor.author | Raykar, Veena | - |
| dc.contributor.author | Kuwabara, Satoshi | - |
| dc.contributor.author | Kim, Seung Hyun | - |
| dc.contributor.author | Sobue, Gen | - |
| dc.contributor.author | Kiernan, Matthew C. | - |
| dc.date.accessioned | 2025-10-02T02:30:26Z | - |
| dc.date.available | 2025-10-02T02:30:26Z | - |
| dc.date.issued | 2025-09 | - |
| dc.identifier.issn | 2666-6065 | - |
| dc.identifier.issn | 2666-6065 | - |
| dc.identifier.uri | https://scholarworks.bwise.kr/hanyang/handle/2021.sw.hanyang/208865 | - |
| dc.description.abstract | The Pan-Asian Consortium for Treatment and Research in ALS (PACTALS) guidelines were developed for the management of amyotrophic lateral sclerosis (ALS) patients living in the Asia-Pacific countries, taking into consideration the ethnic, racial and economic diversity of the region. The majority of patients reside in low-income (limited-resource setting) and middle-income countries. Grading of Recommendations Assessment, Development, and Evaluation (GRADE) methodology was utilised for development of the PACTALS management guidelines. Nine broad research questions, divided into sections, were addressed. Evidence was derived from existing Cochrane reviews, systematic reviews, meta-analysis, and randomized controlled trials (RCT) along with consensus when evidence was limited. Recommendations were provided for diagnostic pathways, use of disease modifying therapies, appropriateness of multidisciplinary care models, management of respiratory dysfunction, communication and nutrition, addressing symptoms that affect the quality of life, managing cognitive, behavioural and emotional symptoms as well as appropriate implementation of palliative care services and addressing end-of-life issues. The PACTALS guidelines provide a much-needed framework for the management of ALS patients living in the Asia-Pacific region. The management guidelines will be updated as the treatment landscape evolves and evidence of novel management approaches becomes available. Copyright (c) 2025 The Author(s). Published by Elsevier Ltd. This is an open access article under the CC BY-NC license (http://creativecommons.org/licenses/by-nc/4.0/). | - |
| dc.format.extent | 31 | - |
| dc.language | 영어 | - |
| dc.language.iso | ENG | - |
| dc.publisher | Elsevier | - |
| dc.title | Pan-Asian consortium for treatment and research in ALS (PACTALS) guidelines for management of amyotrophic lateral sclerosis | - |
| dc.type | Article | - |
| dc.publisher.location | 네델란드 | - |
| dc.identifier.doi | 10.1016/j.lanwpc.2025.101684 | - |
| dc.identifier.scopusid | 2-s2.0-105016018769 | - |
| dc.identifier.wosid | 001575006400001 | - |
| dc.identifier.bibliographicCitation | The Lancet Regional Health. Western Pacific, v.62, pp 1 - 31 | - |
| dc.citation.title | The Lancet Regional Health. Western Pacific | - |
| dc.citation.volume | 62 | - |
| dc.citation.startPage | 1 | - |
| dc.citation.endPage | 31 | - |
| dc.type.docType | Review | - |
| dc.description.isOpenAccess | Y | - |
| dc.description.journalRegisteredClass | scie | - |
| dc.description.journalRegisteredClass | ssci | - |
| dc.description.journalRegisteredClass | scopus | - |
| dc.relation.journalResearchArea | Health Care Sciences & Services | - |
| dc.relation.journalResearchArea | Public, Environmental & Occupational Health | - |
| dc.relation.journalWebOfScienceCategory | Health Care Sciences & Services | - |
| dc.relation.journalWebOfScienceCategory | Public, Environmental & Occupational Health | - |
| dc.subject.keywordPlus | MOTOR-NEURON DISEASE | - |
| dc.subject.keywordPlus | QUALITY-OF-LIFE | - |
| dc.subject.keywordPlus | COLONY-STIMULATING FACTOR | - |
| dc.subject.keywordPlus | EARLY NONINVASIVE VENTILATION | - |
| dc.subject.keywordPlus | MESENCHYMAL STEM-CELLS | - |
| dc.subject.keywordPlus | GOLD-COAST CRITERIA | - |
| dc.subject.keywordPlus | BOTULINUM-TOXIN-A | - |
| dc.subject.keywordPlus | DOUBLE-BLIND | - |
| dc.subject.keywordPlus | PALLIATIVE CARE | - |
| dc.subject.keywordPlus | MULTIDISCIPLINARY CARE | - |
| dc.subject.keywordAuthor | ALS | - |
| dc.subject.keywordAuthor | GRADE | - |
| dc.subject.keywordAuthor | MND | - |
| dc.subject.keywordAuthor | PICO | - |
| dc.identifier.url | https://www.sciencedirect.com/science/article/pii/S2666606525002238?via%3Dihub | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
222, Wangsimni-ro, Seongdong-gu, Seoul, 04763, Korea+82-2-2220-1366
COPYRIGHT © 2024 HANYANG UNIVERSITY.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.
